Research / CRNC / Fundamental state Inspectable configuration
State dimensions Filing 0000950170-22-025785 General Corporate
Debt relative to revenue 9th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.debt_to_revenue
82.46% · OPTIONAL · VALID
Capex intensity 64th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.capex_revenue_ratio
5.32% · OPTIONAL · VALID
Operating cash generation 18th Own-history percentile · N=11
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-0.65% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-15.31% · CORE · NOT_ENOUGH_HISTORY
Gross margin 36th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.gross_margin
70.37% · CORE · VALID
Operating margin 0th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.operating_margin
-56.22% · CORE · VALID
R&D intensity 91th Own-history percentile · N=11
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
32.67% · OPTIONAL · VALID
SBC intensity 27th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
8.56% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 27 states Self-history eligible
Sep 30, 2021 0/8 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/8 normalized Level 3 Jun 30, 2022 7/8 normalized Level 3 Sep 30, 2022 7/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/9 normalized Level 3 Mar 31, 2024 8/9 normalized Level 3 Jun 30, 2024 8/9 normalized Level 3 Sep 30, 2024 8/9 normalized Level 3 Dec 31, 2024 8/9 normalized Level 3 Mar 31, 2025 8/9 normalized Level 3 Jun 30, 2025 8/9 normalized Level 3 Sep 30, 2025 8/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 303.88%
Current 82.46%
Delta -221.42% Capex Intensity Increased
Previous 4.98%
Current 5.32%
Delta 0.34% Cash Generation Increased
Previous -4.41%
Current -0.65%
Delta 3.76% Growth Decreased
Previous -8.02%
Current -15.31%
Delta -7.30% Margin Decreased
Previous 72.76%
Current 70.37%
Delta -2.40% Profitability Decreased
Previous 17.72%
Current -56.22%
Delta -73.94% R And D Intensity Increased
Previous 29.25%
Current 32.67%
Delta 3.42% Sbc Intensity Increased
Previous 7.02%
Current 8.56%
Delta 1.54% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.